author_facet Comi, Giancarlo
Cook, Stuart
Rammohan, Kottil
Soelberg Sorensen, Per
Vermersch, Patrick
Adeniji, Abidemi K.
Dangond, Fernando
Giovannoni, Gavin
Comi, Giancarlo
Cook, Stuart
Rammohan, Kottil
Soelberg Sorensen, Per
Vermersch, Patrick
Adeniji, Abidemi K.
Dangond, Fernando
Giovannoni, Gavin
author Comi, Giancarlo
Cook, Stuart
Rammohan, Kottil
Soelberg Sorensen, Per
Vermersch, Patrick
Adeniji, Abidemi K.
Dangond, Fernando
Giovannoni, Gavin
spellingShingle Comi, Giancarlo
Cook, Stuart
Rammohan, Kottil
Soelberg Sorensen, Per
Vermersch, Patrick
Adeniji, Abidemi K.
Dangond, Fernando
Giovannoni, Gavin
Therapeutic Advances in Neurological Disorders
Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study
Neurology (clinical)
Neurology
Pharmacology
author_sort comi, giancarlo
spelling Comi, Giancarlo Cook, Stuart Rammohan, Kottil Soelberg Sorensen, Per Vermersch, Patrick Adeniji, Abidemi K. Dangond, Fernando Giovannoni, Gavin 1756-2864 1756-2864 SAGE Publications Neurology (clinical) Neurology Pharmacology http://dx.doi.org/10.1177/1756285617753365 Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study Therapeutic Advances in Neurological Disorders
doi_str_mv 10.1177/1756285617753365
facet_avail Online
Free
finc_class_facet Medizin
Chemie und Pharmazie
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE3Ny8xNzU2Mjg1NjE3NzUzMzY1
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE3Ny8xNzU2Mjg1NjE3NzUzMzY1
institution DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
imprint SAGE Publications, 2018
imprint_str_mv SAGE Publications, 2018
issn 1756-2864
issn_str_mv 1756-2864
language English
mega_collection SAGE Publications (CrossRef)
match_str comi2018longtermeffectsofcladribinetabletsonmriactivityoutcomesinpatientswithrelapsingremittingmultiplesclerosistheclarityextensionstudy
publishDateSort 2018
publisher SAGE Publications
recordtype ai
record_format ai
series Therapeutic Advances in Neurological Disorders
source_id 49
title Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study
title_unstemmed Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study
title_full Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study
title_fullStr Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study
title_full_unstemmed Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study
title_short Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study
title_sort long-term effects of cladribine tablets on mri activity outcomes in patients with relapsing–remitting multiple sclerosis: the clarity extension study
topic Neurology (clinical)
Neurology
Pharmacology
url http://dx.doi.org/10.1177/1756285617753365
publishDate 2018
physical 175628561775336
description
container_start_page 0
container_title Therapeutic Advances in Neurological Disorders
container_volume 11
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792342322212503558
geogr_code not assigned
last_indexed 2024-03-01T16:33:58.781Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Long-term+effects+of+cladribine+tablets+on+MRI+activity+outcomes+in+patients+with+relapsing%E2%80%93remitting+multiple+sclerosis%3A+the+CLARITY+Extension+study&rft.date=2018-01-01&genre=article&issn=1756-2864&volume=11&pages=175628561775336&jtitle=Therapeutic+Advances+in+Neurological+Disorders&atitle=Long-term+effects+of+cladribine+tablets+on+MRI+activity+outcomes+in+patients+with+relapsing%E2%80%93remitting+multiple+sclerosis%3A+the+CLARITY+Extension+study&aulast=Giovannoni&aufirst=Gavin&rft_id=info%3Adoi%2F10.1177%2F1756285617753365&rft.language%5B0%5D=eng
SOLR
_version_ 1792342322212503558
author Comi, Giancarlo, Cook, Stuart, Rammohan, Kottil, Soelberg Sorensen, Per, Vermersch, Patrick, Adeniji, Abidemi K., Dangond, Fernando, Giovannoni, Gavin
author_facet Comi, Giancarlo, Cook, Stuart, Rammohan, Kottil, Soelberg Sorensen, Per, Vermersch, Patrick, Adeniji, Abidemi K., Dangond, Fernando, Giovannoni, Gavin, Comi, Giancarlo, Cook, Stuart, Rammohan, Kottil, Soelberg Sorensen, Per, Vermersch, Patrick, Adeniji, Abidemi K., Dangond, Fernando, Giovannoni, Gavin
author_sort comi, giancarlo
container_start_page 0
container_title Therapeutic Advances in Neurological Disorders
container_volume 11
description
doi_str_mv 10.1177/1756285617753365
facet_avail Online, Free
finc_class_facet Medizin, Chemie und Pharmazie
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE3Ny8xNzU2Mjg1NjE3NzUzMzY1
imprint SAGE Publications, 2018
imprint_str_mv SAGE Publications, 2018
institution DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1
issn 1756-2864
issn_str_mv 1756-2864
language English
last_indexed 2024-03-01T16:33:58.781Z
match_str comi2018longtermeffectsofcladribinetabletsonmriactivityoutcomesinpatientswithrelapsingremittingmultiplesclerosistheclarityextensionstudy
mega_collection SAGE Publications (CrossRef)
physical 175628561775336
publishDate 2018
publishDateSort 2018
publisher SAGE Publications
record_format ai
recordtype ai
series Therapeutic Advances in Neurological Disorders
source_id 49
spelling Comi, Giancarlo Cook, Stuart Rammohan, Kottil Soelberg Sorensen, Per Vermersch, Patrick Adeniji, Abidemi K. Dangond, Fernando Giovannoni, Gavin 1756-2864 1756-2864 SAGE Publications Neurology (clinical) Neurology Pharmacology http://dx.doi.org/10.1177/1756285617753365 Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study Therapeutic Advances in Neurological Disorders
spellingShingle Comi, Giancarlo, Cook, Stuart, Rammohan, Kottil, Soelberg Sorensen, Per, Vermersch, Patrick, Adeniji, Abidemi K., Dangond, Fernando, Giovannoni, Gavin, Therapeutic Advances in Neurological Disorders, Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study, Neurology (clinical), Neurology, Pharmacology
title Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study
title_full Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study
title_fullStr Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study
title_full_unstemmed Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study
title_short Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study
title_sort long-term effects of cladribine tablets on mri activity outcomes in patients with relapsing–remitting multiple sclerosis: the clarity extension study
title_unstemmed Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study
topic Neurology (clinical), Neurology, Pharmacology
url http://dx.doi.org/10.1177/1756285617753365